Dr. Wani, is an associate professor of Organic and Medicinal Chemistry in the College of Science, University of Jeddah, Jeddah, Saudi Arabia. He received his Ph.D. in Organic and Medicinal Chemistry from Jamia Millia Islamia, New Delhi, India, and Postdoctoral training from the University of Coimbra, Portugal, and Texas Therapeutics Institute, UTHealth, Houston, Texas, USA on the development of new treatment strategies and non-traditional approaches to combat antimicrobial drug resistance (AMR). With an extensive experience in the field of medicinal chemistry and drug discovery, he has authored/co-authored over 50 peer-reviewed research articles and 04 books, and is the recipient of many prestigious honors, awards, and grants. He is a professional member of many scientific societies and is on the editorial board of many reputed scientific journals. Dr. Wani is working at the interface of chemistry and biology to advance the field with new questions and pertinent issues of 21st century.Dr. Aijaz Ahmad, is a Senior Medical Scientist in the Division of Infection Control of National Health Laboratory Service at Charlotte Maxeke Johannesburg Academic Hospital and a Lecturer in the Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand. His core research interest is understanding fungal pathogenesis and development of antifungal vaccines and novel antifungal drugs. He has obtained his Ph.D. in Medical Mycology. During his trainings as a Postdoctoral Scientist from different institutions, he gained lot of experience to be a medical microbiologist. He is an HPCSA registered Medical Scientist in Microbiology and is also National Research Foundation (NRF) rated researcher. With an extensive research experience in infectious diseases, microbial pathogenesis, and drug development, he has authored/co-authored over 90 peer-reviewed publications, supervised more than 25 postgraduate students, and is recipient of several research grants and awards.

• Chapter 1. Recent Strategies to Combat Multi-drug Resistance.- Chapter 2. Role of advanced therapeutic techniques to combat multi-drug resistance.- Chapter 3. Strategies to combat multidrug resistance by non-traditional therapeutic approaches.- Chapter 4. Treatment Strategies to Combat Multi-drug Resistance (MDR) in Bacteria.- Chapter 5. Alternative therapy options for pathogenic yeasts: Targeting virulence factors with non-conventional antifungals.- Chapter 6. Role of Bacteriophages as non-traditional approaches to combat multidrug resistance.- Chapter 7. Drug Repurposing: An Approach for Reducing Multi Drug Resistance.- Chapter 8. Quorum Sensing as an alternative approach to combatting multidrug resistance.- Chapter 9. Nanoengineering approaches to fight multidrug resistant bacteria.- Chapter 10. Quorum sensing mediated targeted delivery of antibiotics. Chapter 11. Metal chelation as a promising strategy to combat fungal drug resistance.- Chapter 12. Propolis: Natural Antibiotic to Combat Multi Drug-Resistant Bacteria.- Chapter 13. Therapeutic potential of Himalayan Ayurvedic herbs against multidrug-resistant fungal pathogens.- Chapter 14. Antimicrobial Stewardship Programme: Why is it needed?.

Dr. Wani, is an associate professor of Organic and Medicinal Chemistry in the College of Science, University of Jeddah, Jeddah, Saudi Arabia. He received his Ph.D. in Organic and Medicinal Chemistry from Jamia Millia Islamia, New Delhi, India, and Postdoctoral training from the University of Coimbra, Portugal, and Texas Therapeutics Institute, UTHealth, Houston, Texas, USA on the development of new treatment strategies and non-traditional approaches to combat antimicrobial drug resistance (AMR). With an extensive experience in the field of medicinal chemistry and drug discovery, he has authored/co-authored over 50 peer-reviewed research articles and 04 books, and is the recipient of many prestigious honors, awards, and grants. He is a professional member of many scientific societies and is on the editorial board of many reputed scientific journals. Dr. Wani is working at the interface of chemistry and biology to advance the field with new questions and pertinent issues of 21st century.Dr. Aijaz Ahmad, is a Senior Medical Scientist in the Division of Infection Control of National Health Laboratory Service at Charlotte Maxeke Johannesburg Academic Hospital and a Lecturer in the Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand. His core research interest is understanding fungal pathogenesis and development of antifungal vaccines and novel antifungal drugs. He has obtained his Ph.D. in Medical Mycology. During his trainings as a Postdoctoral Scientist from different institutions, he gained lot of experience to be a medical microbiologist. He is an HPCSA registered Medical Scientist in Microbiology and is also National Research Foundation (NRF) rated researcher. With an extensive research experience in infectious diseases, microbial pathogenesis, and drug development, he has authored/co-authored over 90 peer-reviewed publications, supervised more than 25 postgraduate students, and is recipient of several research grants and awards.

• Chapter 1. Recent Strategies to Combat Multi-drug Resistance.- Chapter 2. Role of advanced therapeutic techniques to combat multi-drug resistance.- Chapter 3. Strategies to combat multidrug resistance by non-traditional therapeutic approaches.- Chapter 4. Treatment Strategies to Combat Multi-drug Resistance (MDR) in Bacteria.- Chapter 5. Alternative therapy options for pathogenic yeasts: Targeting virulence factors with non-conventional antifungals.- Chapter 6. Role of Bacteriophages as non-traditional approaches to combat multidrug resistance.- Chapter 7. Drug Repurposing: An Approach for Reducing Multi Drug Resistance.- Chapter 8. Quorum Sensing as an alternative approach to combatting multidrug resistance.- Chapter 9. Nanoengineering approaches to fight multidrug resistant bacteria.- Chapter 10. Quorum sensing mediated targeted delivery of antibiotics. Chapter 11. Metal chelation as a promising strategy to combat fungal drug resistance.- Chapter 12. Propolis: Natural Antibiotic to Combat Multi Drug-Resistant Bacteria.- Chapter 13. Therapeutic potential of Himalayan Ayurvedic herbs against multidrug-resistant fungal pathogens.- Chapter 14. Antimicrobial Stewardship Programme: Why is it needed?.

Dr. Wani, is an associate professor of Organic and Medicinal Chemistry in the College of Science, University of Jeddah, Jeddah, Saudi Arabia. He received his Ph.D. in Organic and Medicinal Chemistry from Jamia Millia Islamia, New Delhi, India, and Postdoctoral training from the University of Coimbra, Portugal, and Texas Therapeutics Institute, UTHealth, Houston, Texas, USA on the development of new treatment strategies and non-traditional approaches to combat antimicrobial drug resistance (AMR). With an extensive experience in the field of medicinal chemistry and drug discovery, he has authored/co-authored over 50 peer-reviewed research articles and 04 books, and is the recipient of many prestigious honors, awards, and grants. He is a professional member of many scientific societies and is on the editorial board of many reputed scientific journals. Dr. Wani is working at the interface of chemistry and biology to advance the field with new questions and pertinent issues of 21st century.Dr. Aijaz Ahmad, is a Senior Medical Scientist in the Division of Infection Control of National Health Laboratory Service at Charlotte Maxeke Johannesburg Academic Hospital and a Lecturer in the Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand. His core research interest is understanding fungal pathogenesis and development of antifungal vaccines and novel antifungal drugs. He has obtained his Ph.D. in Medical Mycology. During his trainings as a Postdoctoral Scientist from different institutions, he gained lot of experience to be a medical microbiologist. He is an HPCSA registered Medical Scientist in Microbiology and is also National Research Foundation (NRF) rated researcher. With an extensive research experience in infectious diseases, microbial pathogenesis, and drug development, he has authored/co-authored over 90 peer-reviewed publications, supervised more than 25 postgraduate students, and is recipient of several research grants and awards.

• Chapter 1. Recent Strategies to Combat Multi-drug Resistance.- Chapter 2. Role of advanced therapeutic techniques to combat multi-drug resistance.- Chapter 3. Strategies to combat multidrug resistance by non-traditional therapeutic approaches.- Chapter 4. Treatment Strategies to Combat Multi-drug Resistance (MDR) in Bacteria.- Chapter 5. Alternative therapy options for pathogenic yeasts: Targeting virulence factors with non-conventional antifungals.- Chapter 6. Role of Bacteriophages as non-traditional approaches to combat multidrug resistance.- Chapter 7. Drug Repurposing: An Approach for Reducing Multi Drug Resistance.- Chapter 8. Quorum Sensing as an alternative approach to combatting multidrug resistance.- Chapter 9. Nanoengineering approaches to fight multidrug resistant bacteria.- Chapter 10. Quorum sensing mediated targeted delivery of antibiotics. Chapter 11. Metal chelation as a promising strategy to combat fungal drug resistance.- Chapter 12. Propolis: Natural Antibiotic to Combat Multi Drug-Resistant Bacteria.- Chapter 13. Therapeutic potential of Himalayan Ayurvedic herbs against multidrug-resistant fungal pathogens.- Chapter 14. Antimicrobial Stewardship Programme: Why is it needed?.